No abstract

No abstract

No abstract

This study is concerned with a novel mass microalgae production system which, for the first time, uses "centrate", a concentrated wastewater stream, to produce microalgal biomass for energy production. Centrate contains a high level of nutrients that support algal growth. The objective of this study was to investigate the growth characteristics of a locally isolated microalgae strain Chlorella sp. in centrate and its ability to remove nutrients from centrate. A pilot-scale photobioreactor (PBR) was constructed at a local wastewater treatment plant. The system was tested under different harvesting rates and exogenous CO(2) levels with the local strain of Chlorella sp. Under low light conditions (25 μmol·m(-2)s(-1)) the system can produce 34.6 and 17.7 g·m(-2)day(-1) biomass in terms of total suspended solids and volatile suspended solids, respectively. At a one fourth harvesting rate, reduction of chemical oxygen demand, total Kjeldahl nitrogen, and soluble total phosphorus were 70%, 61%, and 61%, respectively. The addition of CO(2) to the system did not exhibit a positive effect on biomass productivity or nutrient removal in centrate which is an organic carbon rich medium. The unique PBR system is highly scalable and provides a great opportunity for biomass production coupled with wastewater treatment.

No abstract

No abstract

The results support the hypothesis that RCA can reduce radial transport of some nutrients in some genotypes, which could be an important trade-off of this trait.

This is a new golden age for drug discovery based on natural products derived from both marine and terrestrial sources. Herein, a straightforward but important question is "what are the major structural differences between marine natural products (MNPs) and terrestrial natural products (TNPs)?" To answer this question, we analyzed the important physicochemical properties, structural features, and drug-likeness of the two types of natural products and discussed their differences from the perspective of evolution. In general, MNPs have lower solubility and are often larger than TNPs. On average, particularly from the perspective of unique fragments and scaffolds, MNPs usually possess more long chains and large rings, especially 8- to 10-membered rings. MNPs also have more nitrogen atoms and halogens, notably bromines, and fewer oxygen atoms, suggesting that MNPs may be synthesized by more diverse biosynthetic pathways than TNPs. Analysis of the frequently occurring Murcko frameworks in MNPs and TNPS also reveals a striking difference between MNPs and TNPs. The scaffolds of the former tend to be longer and often contain ester bonds connected to 10-membered rings, while the scaffolds of the latter tend to be shorter and often bear more stable ring systems and bond types. Besides, the prediction from the naïve Bayesian drug-likeness classification model suggests that most compounds in MNPs and TNPs are drug-like, although MNPs are slightly more drug-like than TNPs. We believe that MNPs and TNPs with novel drug-like scaffolds have great potential to be drug leads or drug candidates in drug discovery campaigns.